Long-term safety and clinical effectiveness of controlled-release metoclopramide in cancer-associated dyspepsia syndrome: A multicentre evaluation

Journal of Palliative Care

Volumn 18, Issue 2, 2002, Pages 84-91

  Wilson, Jonathan ^a   Plourde, Jean Yves ^b   Marshall, Denise ^c   Yoshida, Sam ^d   Chow, Winston ^e   Harsanyi, Zoltan ^f   Pearen, Susan ^f   Darke, Andrew ^f  

^a HUMBER RIVER REGIONAL HOSPITAL   (Canada)

^b Hôpital Dr George D Dumont   (Canada)

^c West Lincoln Memorial Hospital   (Canada)

^d Centre Regional De Cancerologie De Windsor   (Canada)

^e York County Hospital   (Canada)

^f PURDUE PHARMA L P   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; METOCLOPRAMIDE;

ADULT; AGED; ANALYSIS OF VARIANCE; ANOREXIA; ARTICLE; CLINICAL TRIAL; DELAYED RELEASE FORMULATION; DYSPEPSIA; FEMALE; HUMAN; MALE; META ANALYSIS; MIDDLE AGED; NAUSEA; NEOPLASM; SYNDROME; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANOREXIA; ANTIEMETICS; DELAYED-ACTION PREPARATIONS; DOPAMINE ANTAGONISTS; DYSPEPSIA; FEMALE; HUMANS; MALE; METOCLOPRAMIDE; MIDDLE AGED; NAUSEA; NEOPLASMS; SYNDROME; TREATMENT OUTCOME; VOMITING;

EID: 0036598685     PISSN: 08258597     EISSN: None     Source Type: Journal    
DOI: 10.1177/082585970201800203     Document Type: Article

References (45)

1. Curtis EB, Krech R, Walsh TD. Common symptoms in patients with advanced cancer. J Palliat Care 1991; 7(2): 25-29.
2. Reuben DB, Mor V. Nausea and vomiting in terminal cancer patients. Arch Intern Med 1986; 146(10): 2021-2023.
3. Baines M. Nausea and vomiting in the patient with advanced cancer. J Pain Symptom Manage 1988; 3(2): 81-85.
4. Bruera E. Update on adjuvant drugs in patients with cancer. In: Bond MR, Charlton JE, Woolf CJ. Proceedings of the World Congress on Pain. Adelaide, Australia, 1990. New York: Elsevier, 1991; ch 57: pp. 459-465.
5. Bruera E, Catz Z, Hooper R, Lentle B, MacDonald N. Chronic nausea and anorexia in advanced cancer patients: a possible role for autonomic dysfunction. J Pain Symptom Manage 1987; 2(1): 19-21.
6. Nelson KA, Walsh TD. Metoclopramide in anorexia caused by cancer-associated dyspepsia syndrome (CADS). J Palliat Care 1993; 9(2): 14-18.
7. Tisdale MJ. Biology of cachexia. J Natl Cancer Inst 1997; 89(23): 1763-1773.
8. Bruera E. Anorexia and cachexia in advanced cancer patients. In: Why do we Care? Pain and symptom control, psychiatric issues and ethical dilemmas in the care of patients with cancer. Syllabus of the postgraduate course. NY: Memorial Sloan-Kettering Cancer Centre, 1992; pp. 315-327.
9. Walsh TD, West TS. Controlling symptoms in advanced cancer. Br Med J 1988; 296(6620): 477-481.
10. Theologides A. Cancer cachexia. Cancer 1979; 43(suppl 5): 2004-2012.
11. Bruera E, Chadwick S, Fox R, Hanson J, MacDonald N. Study of cardiovascular autonomic insufficiency in advanced cancer patients. Cancer Treat Rep 1986; 70(12): 1383-1387.
12. Rubin A, Winston J. The role of the vestibular apparatus in the production of nausea and vomiting following the administration of morphine to man. J Clin Invest 1950; 29: 1261-1266.
13. Comroe JH, Dripps RD. Reactions to morphine in ambulatory and bed patients. Surg Gynecol Obstet 1948; 87: 221-224.
14. Bellville JW, Bross IDJ, Howland WS. Postoperative nausea and vomiting. IV. Factors related to postoperative nausea and vomiting. Anesthesiol 1960; 21(2): 186-193.
15. Burtles R, Peckettt BW. Postoperative vomiting: some factors affecting its incidence. Br J Anaesth 1957; 29: 114-123.
16. Riding JE. Minor complications of general anesthesia. Br J Anaesth 1975 Feb; 47(2): 91-101.
17. Purkis IE. Factors that influence postoperative vomiting. Can Anesth Soc 1964 July; 11(4): 335-339.
18. Nimmo WS. Effect of anaesthesia on gastric motility and emptying. Br J Anaesth 1984 Jan; 56(1): 29-36.
19. th annual meeting of American Society Clinical Oncology; 1993 May 16-18; Orlando, Florida; p. 459.
20. Borison HL, Wang SC. Physiology and pharmacology of vomiting. Pharmacol Rev 1953; 5: 193-230.
21. Costello DJ, Borison HL. Naloxone antagonizes narcotic self-blockade of emesis in the cat. J Pharmacol Exp Ther 1977; 203(1): 222-230.
22. Stewart JJ, Weisbrodt NW, Burks TF. Intestinal reverse peristalsis associated with morphine-induced vomiting. In: Kosterlitz HW, editor. Opiates and endogenous opioid peptides. Amsterdam: Elsevier; 1976; p. 439.
23. Harrington RA, Hamilton CW, Brogden RN, Linkewich JA, Romankiewicz JA, Heel RC. Metoclopramide. An updated review of its pharmacological properties and clinical use. Drugs 1983; 25(5): 451-494.
24. Mitchelson F. Pharmacological agents affecting emesis. A review (Part I). Drugs 1992; 43(3): 295-315.
25. Gralla RJ, Itri LM, Pisko SE, Squillante AE, Kelsen DP, Braun DW Jr, et al. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med 1981; 305(16): 905-909.
26. Schwartz J-C, Agid Y, Bouthenet M-L Neurochemical investigations into the human area postrema. In: Davis CJ, Lake-Bakaar GV, Grahame-Smith DG (eds). Nausea and Vomiting: Mechanisms and Treatment. Berlin: Springer-Verlag, 1986; pp.10-17.
27. Perkel MS, Moore C, Hersh T, Davidson ED. Metoclopramide therapy in patients with delayed gastric emptying: a randomized, double-blind study. Dig Dis Sci 1979; 24(9): 662-666.
28. Snape WJ Jr, Battle WM, Schwartz SS, Braunstein SN, Goldstein HA, Avali A. Metoclopramide to treat gastroparesis due to diabetes mellitus: a double-blind, controlled trial. Ann Intern Med 1982; 96(4): 444-446.
29. McCallum RW, Ricci DA, Rakatansky H, Behar J, Rhodes JB, Salen G, et al. A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care 1983; 6(5): 463-467.
30. Loo FD, Palmer DW, Soergel KH, Kalbfleisch JH, Wood CM. Gastric emptying in patients with diabetes mellitus. Gastroenterology 1984; 86(3): 485-494.
31. Schade RR, Dugas MC, Lhotsky DM, Gavaler JS, Van Thiel DH. Effect of metoclopramide on gastric liquid emptying in patients with diabetic gastroparesis. Dig Dis Sci 1985; 30(1): 10-15.
32. Shivshanker K, Bennett RW Jr, Haynie TP. Tumor-associated gastroparesis: correction with metoclopramide. Am J Surg 1983; 145(2): 221-225.
33. Thomas JP, Shields R. Associated autonomic dysfunction and carcinoma of the pancreas. Br Med J 1970; 4(726): 32.
34. Bruera E, MacDonald N, Brenneis C, Simpson I, LeGatt D. Metoclopramide infusion with a disposable portable pump. Ann Intern Med 1986; 104(6): 896.
35. st annual meeting of the American Society Clinical Oncology; 1985, May 19-21, Houston, Texas; p. 267.
36. Bruera E, Seifert L, Watanabe S, Babul N, Darke A, Harsanyi Z, et al. Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramidebased antiemetic regimen. J Pain Symptom Manage 1996; 11(3): 147-153.
37. Bruera ED, MacEachem TJ, Spachynski KA, LeGatt DF, MacDonald RN, Babul N, et al. Comparison of the efficacy, safety and pharmacokinetics of controlled-release and immediate release metoclopramide for the management of chronic nausea in patients with advanced cancer. Cancer 1994; 74(12): 3204-3211.
38. Bruera E, Belzile M, Neumann C, Harsanyi Z, Babul N, Darke A. A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage 2000; 19(6): 427-435.
39. Bliss JM, Robertson B, Selby PJ. The impact of nausea and vomiting upon quality of life measures. Br J Cancer Suppl 1992; 19: S14-S22, discussion S23.
40. Blackburn G, Miller M, Bother A. Nutritional factors in cancer in medical oncology. In: Calabresi P, Schein PS, Rosenberg SA, Schein PS (eds). Medical Oncology: Basic Principles and Clinical Management of Cancer. New York: Macmillan Publishing Co., 1985; pp.1406-1432.
41. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980; 69(4): 491-497.
42. Bruera E, MacDonald RN. Nutrition in cancer patients: an update and review of our experience. Issues in symptom control. Part 3. J Pain Symptom Manage 1988; 3(3): 133-140.
43. Chestnut DH, Vandewalker GE, Owen CL, Bates JN, Choi WW. Administration of metoclopramide for prevention of nausea and vomiting during epidural anaesthesia for elective cesarean section. Anesthesiology 1987; 66(4): 563-566.
44. Kauste A, Tuominen M, Heikkinen H, Gordin A, Korttilla K. Droperidol, alizapride and metoclopramide in the prevention and treatment of post-operative emetic sequelae. Eur J Anaesthesiol 1986; 3(1): 1-9.
45. Assaf RA, Clarke RS, Dundee JW, Samuel IO. Studies of drugs given before anesthesia XXIV: Metoclopramide with morphine and pethidine. Br J Anaesth 1974; 46(7): 514-519.